Robuta

https://pmlive.com/digital_edition/pme_supplements/diversity_equity_and_inclusion_1451077/ Diversity, equity and inclusion - PMLiVE Diversity, equity and inclusion in the workplace diversity equityinclusion https://pmlive.com/register-for-a-pmhub-account/ Register for a PMHub account - PMLiVE Feb 8, 2024 - Adding your company profile to PMHub is a simple process. registeraccountpmlive https://pmlive.com/digital_edition/communique/communique_-_volume_53/ Communiqué - Volume 53 - PMLiVE New insights in health comms innovation. Communiqué Awards 2022 – winners’ case studies. INSIGHTS – Demonstrating impact • Driving behaviour change volumepmlive https://pmlive.com/intelligence/optimised-therapy-to-improve-outcomes-for-heart-attack-and-stroke-patients/ Optimised therapy to improve outcomes for heart attack and stroke patients - PMLiVE Dec 4, 2025 - Personalising therapy promises to revolutionise the treatment of thrombosis improve outcomesheart attack https://pmlive.com/pharma_news/regenerons-libtayo-receives-ec-approval-for-skin-cancer/ Regeneron’s Libtayo receives EC approval for skin cancer - PMLiVE Nov 28, 2025 - Phase 3 trial results showed the drug significantly improved disease-free survival skin cancerreceivesapproval https://pmlive.com/pharma_news/tonix-launches-new-oral-fibromyalgia-treatment/ Tonix launches new oral fibromyalgia treatment - PMLiVE Nov 27, 2025 - Tonmya is the first approved treatment for adults with fibromyalgia in over 15 years launches newtreatment pmlive https://pmlive.com/intelligence/a-new-advent-of-clinical-pathway-management/ A new advent of clinical pathway management - PMLiVE Nov 6, 2025 - Platelet functionality analysis could pave the way to improving drug asset selection and de-risking clinical trials newadventclinicalpathway https://pmlive.com/intelligence/genai-tools-creating-a-new-era-of-scientific-research/ GenAI tools – creating a new era of scientific research - PMLiVE Nov 12, 2025 - The new wave of GenAI-powered search tools now offers researchers an alternative method for accessing insights at speed genai toolsnew eracreating https://pmlive.com/ PMLiVE | Pharmaceutical industry news, articles, jobs, reports, advice and services pharmaceutical industrypmlive https://pmlive.com/intelligence/esmo-2025-ensuring-innovation-isnt-lost-in-translation/ ESMO 2025 – ensuring innovation isn’t lost in translation - PMLiVE Nov 28, 2025 - This year marks the congress’s 50th anniversary, with the theme: Many journeys. One global community esmoensuringinnovationlost https://pmlive.com/pharma_news/sandoz-launches-first-and-only-multiple-sclerosis-biosimilar-in-us/ Sandoz launches first and only multiple sclerosis biosimilar in US - PMLiVE Nov 27, 2025 - The treatment is FDA-approved to treat MS and Crohn’s disease launches firstsandozmultiple https://pmlive.com/intelligence/from-disruption-to-resilience-indias-growing-role-in-pharma-logistics/ From disruption to resilience: India’s growing role in pharma logistics - PMLiVE Nov 10, 2025 - In light of US tariffs, India’s role as a politically neutral, cost-efficient partner is more critical than ever growing rolepharma logistics https://pmlive.com/pharma_news/bms-takeda-and-astex-join-ai-training-consortium/ BMS, Takeda and Astex join AI training consortium - PMLiVE Oct 2, 2025 - The initiative focuses on training AI models to aid in drug discovery and development ai trainingbmstakedaastexjoin https://pmlive.com/pharma_news/novartis-itvisma-gets-fda-approval-for-spinal-muscular-atrophy-treatment/ Novartis’ Itvisma gets FDA approval for spinal muscular atrophy treatment - PMLiVE Nov 28, 2025 - Around 9,000 people in the US currently live with SMA spinal muscular atrophygets